Morgan Stanley Maintains Overweight on Lam Research, Lowers Price Target to $367

Benzinga Newsdesk www.benzinga.com Negative 88.3%

Neg 88.3% Neu 0% Pos 0%

Morgan Stanley analyst Shane Brett maintains Lam Research (NASDAQ:LRCX) with a Overweight and lowers the price target from $404 to $367.